Ausgabe 2/2018
Inhalt (25 Artikel)
A systematic review of flap fixation techniques in reducing seroma formation and its sequelae after mastectomy
J. van Bastelaar, L. van Roozendaal, R. Granzier, G. Beets, Y. Vissers
Clinical implications of germline mutations in breast cancer: TP53
Katherine Schon, Marc Tischkowitz
Ethnicity and breast cancer characteristics in Kenya
Shahin Sayed, Zahir Moloo, Ronald Wasike, Peter Bird, Raymond Oigara, Faith Wambui Njoroge, Asim Jamal Shaikh, Satya Vara Prasad, Sudhir Vinayak, Gretchen L. Gierach, Sanford M. Dawsey, Maya Palakal, Shaoqi Fan, Maeve Mullooly, Rajendra Chauhan, Patricia Okiro, Samuel Gakinya, Ancent Nzioka, Catherine Kyobutungi, Shukri Mohamed, Tilahun Haregu, Mustafa Mussajee, Betty Bonass, Costa Mariwa, Omar Ali Sherman, Abdihakim Mohammed, Andrew Gachii, Joseph Githaiga, Joseph Karanu, Robert Nyagah, Richard Njoroge, Irene Muramba, James Obondi Otieno, Dan Omondi Raburu, Elizabeth B. Mwachiro, Innocent Abayo, Mansoor Saleh
Acute phase dynamics of circulating tumor cells after paclitaxel and doxorubicin chemotherapy in breast cancer mouse models
Yayoi Adachi, Mayumi Yoshimura, Keiko Nishida, Hisanobu Usuki, Keiko Shibata, Masaya Hattori, Naoto Kondo, Yasushi Yatabe, Hiroji Iwata, Toyone Kikumori, Yasuhiro Kodera, Hayao Nakanishi
The importance of early detection of calcifications associated with breast cancer in screening
J. J. Mordang, A. Gubern-Mérida, A. Bria, F. Tortorella, R. M. Mann, M. J. M. Broeders, G. J. den Heeten, N. Karssemeijer
Canine invasive mammary carcinomas as models of human breast cancer. Part 2: immunophenotypes and prognostic significance
Jérôme Abadie, Frédérique Nguyen, Delphine Loussouarn, Laura Peña, Adelina Gama, Natascha Rieder, Anton Belousov, Ingrid Bemelmans, Laëtitia Jaillardon, Catherine Ibisch, Mario Campone
Phase IB trial of ixabepilone and vorinostat in metastatic breast cancer
Thehang Luu, Kyu-pyo Kim, Suzette Blanchard, Bean Anyang, Arti Hurria, Lixin Yang, Jan H. Beumer, George Somlo, Yun Yen
Discrepancies between biomarkers of primary breast cancer and subsequent brain metastases: an international multicenter study
O. Kaidar-Person, I. Meattini, P. Jain, P. Bult, N. Simone, I. Kindts, R. Steffens, C. Weltens, P. Navarria, Y. Belkacemi, J. Lopez-Guerra, L. Livi, B. G. Baumert, B. Vieites, D. Limon, N. Kurman, K. Ko, J. B. Yu, V. Chiang, P. Poortmans, T. Zagar
A randomized phase II study of weekly paclitaxel with or without pelareorep in patients with metastatic breast cancer: final analysis of Canadian Cancer Trials Group IND.213.
V. Bernstein, S. L. Ellard, S. F. Dent, D. Tu, M. Mates, S. K. Dhesy-Thind, L. Panasci, K. A. Gelmon, M. Salim, X. Song, M. Clemons, D. Ksienski, S. Verma, C. Simmons, H. Lui, K. Chi, H. Feilotter, L. J. Hagerman, L. Seymour
Usefulness of abbreviated breast MRI screening for women with a history of breast cancer surgery
Bo Hwa Choi, Nami Choi, Mi Young Kim, Jung-Hyun Yang, Young Bum Yoo, Hae Kyoung Jung
Correction to: Usefulness of abbreviated breast MRI screening for women with a history of breast cancer surgery
Bo Hwa Choi, Nami Choi, Mi Young Kim, Jung-Hyun Yang, Young Bum Yoo, Hae Kyoung Jung
Exercise following breast cancer: exploratory survival analyses of two randomised, controlled trials
S. C. Hayes, M. L. Steele, R. R. Spence, L. Gordon, D. Battistutta, J. Bashford, C. Pyke, C. Saunders, E. Eakin
Correction to: Exercise following breast cancer: exploratory survival analyses of two randomised, controlled trials
S. C. Hayes, M. L. Steele, R. R. Spence, L. Gordon, D. Battistutta, J. Bashford, C. Pyke, C. Saunders, E. Eakin
Breast cancer recurrence, bone metastases, and visceral metastases in women with stage II and III breast cancer in Denmark
Deirdre Cronin-Fenton, Anders Kjærsgaard, Mette Nørgaard, Justyna Amelio, Alexander Liede, Rohini K. Hernandez, Henrik T. Sørensen
Alcohol consumption across the life course and mammographic density in premenopausal women
Ying Liu, Rulla M. Tamimi, Graham A. Colditz, Kimberly A. Bertrand
Predictors of the quality of life in Chinese breast cancer survivors
Juan Xia, Zheng Tang, Qinglong Deng, Renren Yang, Jiwei Wang, Jinming Yu
Monosomy 17 in potentially curable HER2-amplified breast cancer: prognostic and predictive impact
David B. Page, Hannah Wen, Edi Brogi, Dana Dure, Dara Ross, Kateri J. Spinelli, Sujata Patil, Larry Norton, Clifford Hudis, Heather L. McArthur
Patterns of axillary evaluation in older patients with breast cancer and associations with adjuvant therapy receipt
Laura S. Dominici, Helmneh M. Sineshaw, Ahmedin Jemal, Chun Chieh Lin, Tari A. King, Rachel A. Freedman
Routine treatment and outcome of breast cancer in younger versus elderly patients: results from the SENORA project of the prospective German TMK cohort study
Thomas Fietz, Mark-Oliver Zahn, Andreas Köhler, Erik Engel, Melanie Frank, Lisa Kruggel, Martina Jänicke, Norbert Marschner
Differential presentation and survival of de novo and recurrent metastatic breast cancer over time: 1990–2010
Judith A. Malmgren, Musa Mayer, Mary K. Atwood, Henry G. Kaplan
Serum selenium levels predict survival after breast cancer
J. Lubinski, W. Marciniak, M. Muszynska, T. Huzarski, J. Gronwald, C. Cybulski, A. Jakubowska, T. Debniak, M. Falco, J. Kladny, J. Kotsopoulos, P. Sun, S. A. Narod
Response letter to: Questions about Ki67 staining in luminal breast cancer
Alberto Gallardo, Enrique Lerma
A need for biology-driven personalized radiotherapy in breast cancer
Pelagia G. Tsoutsou, André-Dante Durham, Marie-Catherine Vozenin
Correction to: Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancer
Muhammad Asaduzzaman, Stephanie Constantinou, Haoxiang Min, John Gallon, Meng-Lay Lin, Poonam Singh, Selina Raguz, Simak Ali, Sami Shousha, R. Charles Coombes, Eric W.-F. Lam, Yunhui Hu, Ernesto Yagüe